Report updated May 4, 2026
Re-ALK
For patients diagnosed with ALK-rearranged Non-Small Cell Lung Cancer and their treating physicians.
Overview · Full Intel report in progress
Re-ALK is an established medical app that is completely free. With a 1.5/5 rating from 72 reviews, it shows polarized user reception.
What is Re-ALK?
Current Momentum
v1.1
API和新政策更新，wifi连接稳定性优化等
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Provides educational materials for patients and clinical decision-making algorithms for doctors across various treatment lines.
Allows patients to log adverse events and enables doctors to monitor these reports over time.
Enables patients to set personalized reminders to improve medication adherence.
Offers a platform for direct communication and discussion between patients and medical professionals.
How much does it cost?
Who Built It?
Sowlutions
Connecting individuals through personality-based social matching and relationship management tools. Helping users foster more meaningful personal and professional interactions.
Portfolio
5
Apps
What other apps does Sowlutions make?
Explore the full Sowlutions report
Portfolio breakdown, audience, momentum, and every app published by Sowlutions.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Re-ALK?
How's The Medical Market?
Market outlook for this category
Available very soon
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Re-ALK
Key Takeaways
The app functions as a dual-interface management platform intended to improve treatment adherence and clinical monitoring for a specific oncology patient population.
Where Is It Heading?
Trend analysis
Available very soon